CRISPR Therapeutics AG (CRSP) Shares Outstanding (Diluted) (2015 - 2026)
CRISPR Therapeutics AG (CRSP) posted Weighted Average Shares Outstanding (Diluted) of 96.74 million for Q3 2026, up 6.0% from 91.31 million a year earlier and up 0.2% from the prior quarter.
Powered by 
Analysis
CRISPR Therapeutics AG (CRSP) Shares Outstanding (Diluted) (2015 - 2026) Analysis & Trends
For FY2025, CRISPR Therapeutics AG's Weighted Average Shares Outstanding (Diluted) came in at 89.93 million, up 6.6% from FY2024.
- Annual Weighted Average Shares Outstanding (Diluted) has increased for three consecutive years, with a five-year compound annual growth rate of 6.4% (FY2020 to FY2025).
- In prior years, CRISPR Therapeutics AG's Weighted Average Shares Outstanding (Diluted) was 84.36 million in FY2024 (+6.5%), 79.22 million in FY2023 (+1.9%), 77.75 million in FY2022 (-3.3%) and 80.39 million in FY2021 (+21.9%).
- The Q3 2026 figure stands as the highest quarterly Weighted Average Shares Outstanding (Diluted) in data going back to Q1 2016.
- On a year-over-year basis, Weighted Average Shares Outstanding (Diluted) has increased in each of the last 15 quarters, with growth averaging 7.0% over the last eight quarters.
- The strongest year-over-year quarter for Weighted Average Shares Outstanding (Diluted) in the past five years was Q4 2021, with growth of 21.9%; the weakest was Q2 2022, with a decline of 3.7%.
- According to Business Quant data, Weighted Average Shares Outstanding (Diluted) for the three prior quarters was 96.51 million (Q2 2026), 96.05 million (Q1 2026) and 89.93 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | CRISPR Therapeutics AG | 4.37 Bn | -4.68 Bn | - | 96.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 96.74 Mn |
| Jun 30, 2026 | 96.51 Mn |
| Mar 31, 2026 | 96.05 Mn |
| Dec 31, 2025 | 89.93 Mn |
| Sep 30, 2025 | 91.31 Mn |
| Jun 30, 2025 | 87.07 Mn |
| Mar 31, 2025 | 85.94 Mn |
| Dec 31, 2024 | 84.36 Mn |
| Sep 30, 2024 | 85.23 Mn |
| Jun 30, 2024 | 84.92 Mn |
| Mar 31, 2024 | 81.79 Mn |
| Dec 31, 2023 | 79.22 Mn |
| Sep 30, 2023 | 79.41 Mn |
| Jun 30, 2023 | 79.09 Mn |
| Mar 31, 2023 | 78.68 Mn |
| Dec 31, 2022 | 77.75 Mn |
| Sep 30, 2022 | 78.02 Mn |
| Jun 30, 2022 | 77.51 Mn |
| Mar 31, 2022 | 77.10 Mn |
| Dec 31, 2021 | 80.39 Mn |
API Access
CRISPR Therapeutics AG Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CRSP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "CRSP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CRSP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();